UniProt ID | EIF3C_HUMAN | |
---|---|---|
UniProt AC | Q99613 | |
Protein Name | Eukaryotic translation initiation factor 3 subunit C {ECO:0000255|HAMAP-Rule:MF_03002} | |
Gene Name | EIF3C {ECO:0000255|HAMAP-Rule:MF_03002} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 913 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. [PubMed: 17581632] | |
Protein Sequence | MSRFFTTGSDSESESSLSGEELVTKPVGGNYGKQPLLLSEDEEDTKRVVRSAKDKRFEELTNLIRTIRNAMKIRDVTKCLEEFELLGKAYGKAKSIVDKEGVPRFYIRILADLEDYLNELWEDKEGKKKMNKNNAKALSTLRQKIRKYNRDFESHITSYKQNPEQSADEDAEKNEEDSEGSSDEDEDEDGVSAATFLKKKSEAPSGESRKFLKKMDDEDEDSEDSEDDEDWDTGSTSSDSDSEEEEGKQTALASRFLKKAPTTDEDKKAAEKKREDKAKKKHDRKSKRLDEEEEDNEGGEWERVRGGVPLVKEKPKMFAKGTEITHAVVIKKLNEILQARGKKGTDRAAQIELLQLLVQIAAENNLGEGVIVKIKFNIIASLYDYNPNLATYMKPEMWGKCLDCINELMDILFANPNIFVGENILEESENLHNADQPLRVRGCILTLVERMDEEFTKIMQNTDPHSQEYVEHLKDEAQVCAIIERVQRYLEEKGTTEEVCRIYLLRILHTYYKFDYKAHQRQLTPPEGSSKSEQDQAENEGEDSAVLMERLCKYIYAKDRTDRIRTCAILCHIYHHALHSRWYQARDLMLMSHLQDNIQHADPPVQILYNRTMVQLGICAFRQGLTKDAHNALLDIQSSGRAKELLGQGLLLRSLQERNQEQEKVERRRQVPFHLHINLELLECVYLVSAMLLEIPYMAAHESDARRRMISKQFHHQLRVGERQPLLGPPESMREHVVAASKAMKMGDWKTCHSFIINEKMNGKVWDLFPEADKVRTMLVRKIQEESLRTYLFTYSSVYDSISMETLSDMFELDLPTVHSIISKMIINEELMASLDQPTQTVVMHRTEPTAQQNLALQLAEKLGSLVENNERVFDHKQGTYGGYFRDQKDGYRKNEGYMRRGGYRQQQSQTAY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSRFFTTGS ------CCCCCCCCC | 37.48 | 29514088 | |
6 | Phosphorylation | --MSRFFTTGSDSES --CCCCCCCCCCCCC | 27.77 | 23927012 | |
7 | Phosphorylation | -MSRFFTTGSDSESE -CCCCCCCCCCCCCC | 29.54 | 30278072 | |
9 | Phosphorylation | SRFFTTGSDSESESS CCCCCCCCCCCCCCC | 35.55 | 23927012 | |
11 | Phosphorylation | FFTTGSDSESESSLS CCCCCCCCCCCCCCC | 44.73 | 23927012 | |
13 | Phosphorylation | TTGSDSESESSLSGE CCCCCCCCCCCCCCC | 46.89 | 25159151 | |
15 | Phosphorylation | GSDSESESSLSGEEL CCCCCCCCCCCCCCE | 45.95 | 25159151 | |
16 | Phosphorylation | SDSESESSLSGEELV CCCCCCCCCCCCCEE | 23.62 | 23927012 | |
18 | Phosphorylation | SESESSLSGEELVTK CCCCCCCCCCCEEEC | 46.21 | 23927012 | |
24 | Phosphorylation | LSGEELVTKPVGGNY CCCCCEEECCCCCCC | 42.11 | 23927012 | |
31 | Phosphorylation | TKPVGGNYGKQPLLL ECCCCCCCCCCCCCC | 29.04 | 23927012 | |
39 | Phosphorylation | GKQPLLLSEDEEDTK CCCCCCCCCCHHHHH | 42.86 | 19664994 | |
45 | Phosphorylation | LSEDEEDTKRVVRSA CCCCHHHHHHHHHHH | 24.83 | 22167270 | |
61 | Phosphorylation | DKRFEELTNLIRTIR HHHHHHHHHHHHHHH | 31.12 | - | |
66 | Phosphorylation | ELTNLIRTIRNAMKI HHHHHHHHHHHHHHH | 19.79 | - | |
78 | Acetylation | MKIRDVTKCLEEFEL HHHHHHHHHHHHHHH | 36.35 | 26051181 | |
78 | Ubiquitination | MKIRDVTKCLEEFEL HHHHHHHHHHHHHHH | 36.35 | - | |
79 | Glutathionylation | KIRDVTKCLEEFELL HHHHHHHHHHHHHHH | 4.17 | 22555962 | |
88 | Ubiquitination | EEFELLGKAYGKAKS HHHHHHHHHHCCHHH | 38.10 | - | |
92 | Ubiquitination | LLGKAYGKAKSIVDK HHHHHHCCHHHCCCC | 39.71 | - | |
94 | Ubiquitination | GKAYGKAKSIVDKEG HHHHCCHHHCCCCCC | 44.17 | - | |
95 | Phosphorylation | KAYGKAKSIVDKEGV HHHCCHHHCCCCCCC | 32.48 | 22817900 | |
99 | Acetylation | KAKSIVDKEGVPRFY CHHHCCCCCCCCHHH | 45.53 | 23236377 | |
99 | Ubiquitination | KAKSIVDKEGVPRFY CHHHCCCCCCCCHHH | 45.53 | - | |
104 | Methylation | VDKEGVPRFYIRILA CCCCCCCHHHHHHHH | 34.30 | - | |
124 | Ubiquitination | LNELWEDKEGKKKMN HHHHHCCHHHHHHCC | 57.77 | - | |
127 | Acetylation | LWEDKEGKKKMNKNN HHCCHHHHHHCCHHH | 50.76 | 24431599 | |
128 | Acetylation | WEDKEGKKKMNKNNA HCCHHHHHHCCHHHH | 69.02 | 156801 | |
136 | Acetylation | KMNKNNAKALSTLRQ HCCHHHHHHHHHHHH | 52.57 | 26051181 | |
136 | Malonylation | KMNKNNAKALSTLRQ HCCHHHHHHHHHHHH | 52.57 | 26320211 | |
136 | Ubiquitination | KMNKNNAKALSTLRQ HCCHHHHHHHHHHHH | 52.57 | - | |
140 | Phosphorylation | NNAKALSTLRQKIRK HHHHHHHHHHHHHHH | 27.15 | - | |
148 | Phosphorylation | LRQKIRKYNRDFESH HHHHHHHHHHHHHHH | 12.94 | 21406692 | |
154 | Phosphorylation | KYNRDFESHITSYKQ HHHHHHHHHHHHCCC | 21.86 | 21406692 | |
157 | Phosphorylation | RDFESHITSYKQNPE HHHHHHHHHCCCCCC | 22.15 | 21406692 | |
158 | Phosphorylation | DFESHITSYKQNPEQ HHHHHHHHCCCCCCC | 29.72 | 21406692 | |
159 | Phosphorylation | FESHITSYKQNPEQS HHHHHHHCCCCCCCC | 14.14 | 21406692 | |
160 | Ubiquitination | ESHITSYKQNPEQSA HHHHHHCCCCCCCCC | 43.28 | - | |
166 | Phosphorylation | YKQNPEQSADEDAEK CCCCCCCCCCHHHHH | 35.71 | 29255136 | |
178 | Phosphorylation | AEKNEEDSEGSSDED HHHCHHCCCCCCCCC | 47.33 | 26503892 | |
181 | Phosphorylation | NEEDSEGSSDEDEDE CHHCCCCCCCCCCCC | 30.48 | 26503892 | |
182 | Phosphorylation | EEDSEGSSDEDEDED HHCCCCCCCCCCCCC | 56.74 | 26503892 | |
192 | Phosphorylation | DEDEDGVSAATFLKK CCCCCCCCHHHHHHH | 20.09 | 25850435 | |
195 | Phosphorylation | EDGVSAATFLKKKSE CCCCCHHHHHHHHCC | 29.26 | 25850435 | |
201 | Phosphorylation | ATFLKKKSEAPSGES HHHHHHHCCCCCHHH | 48.12 | 28674151 | |
205 | Phosphorylation | KKKSEAPSGESRKFL HHHCCCCCHHHHHHH | 63.34 | 30576142 | |
208 | Phosphorylation | SEAPSGESRKFLKKM CCCCCHHHHHHHHHC | 44.27 | 28102081 | |
222 | Phosphorylation | MDDEDEDSEDSEDDE CCCCCCCCCCCCCCC | 41.05 | 22210691 | |
225 | Phosphorylation | EDEDSEDSEDDEDWD CCCCCCCCCCCCCCC | 38.58 | 25137130 | |
233 | Phosphorylation | EDDEDWDTGSTSSDS CCCCCCCCCCCCCCC | 28.86 | 25137130 | |
235 | Phosphorylation | DEDWDTGSTSSDSDS CCCCCCCCCCCCCCC | 27.49 | 25137130 | |
236 | Phosphorylation | EDWDTGSTSSDSDSE CCCCCCCCCCCCCCH | 33.33 | 22210691 | |
237 | Phosphorylation | DWDTGSTSSDSDSEE CCCCCCCCCCCCCHH | 33.57 | 25137130 | |
238 | Phosphorylation | WDTGSTSSDSDSEEE CCCCCCCCCCCCHHH | 41.02 | 25137130 | |
240 | Phosphorylation | TGSTSSDSDSEEEEG CCCCCCCCCCHHHHH | 45.01 | 22210691 | |
242 | Phosphorylation | STSSDSDSEEEEGKQ CCCCCCCCHHHHHHH | 51.35 | 26657352 | |
250 | Phosphorylation | EEEEGKQTALASRFL HHHHHHHHHHHHHHH | 27.42 | 24719451 | |
262 | Phosphorylation | RFLKKAPTTDEDKKA HHHHHCCCCHHHHHH | 52.30 | 30576142 | |
263 | Phosphorylation | FLKKAPTTDEDKKAA HHHHCCCCHHHHHHH | 36.01 | 26657352 | |
277 | Acetylation | AEKKREDKAKKKHDR HHHHHHHHHHHHHHH | 58.30 | - | |
286 | Phosphorylation | KKKHDRKSKRLDEEE HHHHHHHHHCCCHHH | 24.73 | 30624053 | |
287 | Acetylation | KKHDRKSKRLDEEEE HHHHHHHHCCCHHHC | 61.08 | 23236377 | |
288 | Methylation | KHDRKSKRLDEEEED HHHHHHHCCCHHHCC | 55.23 | - | |
303 | Methylation | NEGGEWERVRGGVPL CCCCCCEECCCCCCC | 25.22 | - | |
304 | Methylation | EGGEWERVRGGVPLV CCCCCEECCCCCCCC | 4.52 | - | |
305 | Methylation | GGEWERVRGGVPLVK CCCCEECCCCCCCCC | 42.23 | - | |
306 | Methylation | GEWERVRGGVPLVKE CCCEECCCCCCCCCC | 38.30 | - | |
312 | Ubiquitination | RGGVPLVKEKPKMFA CCCCCCCCCCCCCCC | 68.64 | - | |
313 | Ubiquitination | GGVPLVKEKPKMFAK CCCCCCCCCCCCCCC | 68.09 | - | |
320 | Acetylation | EKPKMFAKGTEITHA CCCCCCCCCCCCCHH | 55.91 | 26051181 | |
321 | Ubiquitination | KPKMFAKGTEITHAV CCCCCCCCCCCCHHH | 25.75 | - | |
331 | Acetylation | ITHAVVIKKLNEILQ CCHHHHHHHHHHHHH | 39.33 | 26051181 | |
331 | Ubiquitination | ITHAVVIKKLNEILQ CCHHHHHHHHHHHHH | 39.33 | 21906983 | |
332 | Ubiquitination | THAVVIKKLNEILQA CHHHHHHHHHHHHHH | 45.48 | - | |
333 | Ubiquitination | HAVVIKKLNEILQAR HHHHHHHHHHHHHHC | 6.21 | - | |
446 | Phosphorylation | RVRGCILTLVERMDE HHHHHHHHHHHHCHH | 14.62 | 20068231 | |
447 | Phosphorylation | VRGCILTLVERMDEE HHHHHHHHHHHCHHH | 3.18 | 20068231 | |
462 | Phosphorylation | FTKIMQNTDPHSQEY HHHHHHCCCCCCHHH | 33.73 | 28851738 | |
466 | Phosphorylation | MQNTDPHSQEYVEHL HHCCCCCCHHHHHHH | 30.05 | 28851738 | |
469 | Phosphorylation | TDPHSQEYVEHLKDE CCCCCHHHHHHHHHH | 11.96 | - | |
470 | Phosphorylation | DPHSQEYVEHLKDEA CCCCHHHHHHHHHHH | 3.53 | - | |
474 | Acetylation | QEYVEHLKDEAQVCA HHHHHHHHHHHHHHH | 56.27 | 26051181 | |
475 | Ubiquitination | EYVEHLKDEAQVCAI HHHHHHHHHHHHHHH | 63.92 | - | |
493 | Acetylation | VQRYLEEKGTTEEVC HHHHHHHCCCHHHHH | 52.78 | 26051181 | |
493 | Ubiquitination | VQRYLEEKGTTEEVC HHHHHHHCCCHHHHH | 52.78 | - | |
494 | Ubiquitination | QRYLEEKGTTEEVCR HHHHHHCCCHHHHHH | 40.94 | - | |
513 | Acetylation | RILHTYYKFDYKAHQ HHHHHHHHCCHHHHH | 22.73 | 26051181 | |
513 | Ubiquitination | RILHTYYKFDYKAHQ HHHHHHHHCCHHHHH | 22.73 | - | |
514 | Ubiquitination | ILHTYYKFDYKAHQR HHHHHHHCCHHHHHC | 7.78 | - | |
517 | Acetylation | TYYKFDYKAHQRQLT HHHHCCHHHHHCCCC | 41.03 | 27452117 | |
517 | Ubiquitination | TYYKFDYKAHQRQLT HHHHCCHHHHHCCCC | 41.03 | - | |
518 | Ubiquitination | YYKFDYKAHQRQLTP HHHCCHHHHHCCCCC | 9.60 | - | |
524 | Phosphorylation | KAHQRQLTPPEGSSK HHHHCCCCCCCCCCH | 28.58 | 25159151 | |
525 | Phosphorylation | AHQRQLTPPEGSSKS HHHCCCCCCCCCCHH | 33.27 | 15302935 | |
529 | Phosphorylation | QLTPPEGSSKSEQDQ CCCCCCCCCHHHHHH | 32.69 | 30266825 | |
530 | Phosphorylation | LTPPEGSSKSEQDQA CCCCCCCCHHHHHHH | 51.57 | 30266825 | |
531 | Ubiquitination | TPPEGSSKSEQDQAE CCCCCCCHHHHHHHH | 60.76 | 21890473 | |
532 | Phosphorylation | PPEGSSKSEQDQAEN CCCCCCHHHHHHHHH | 42.30 | 25159151 | |
532 | Ubiquitination | PPEGSSKSEQDQAEN CCCCCCHHHHHHHHH | 42.30 | - | |
533 | Phosphorylation | PEGSSKSEQDQAENE CCCCCHHHHHHHHHC | 63.01 | - | |
544 | Phosphorylation | AENEGEDSAVLMERL HHHCCCHHHHHHHHH | 18.90 | 23322592 | |
548 | Acetylation | GEDSAVLMERLCKYI CCHHHHHHHHHHHHH | 1.95 | 19608861 | |
550 | Methylation | DSAVLMERLCKYIYA HHHHHHHHHHHHHHH | 31.27 | - | |
551 | Methylation | SAVLMERLCKYIYAK HHHHHHHHHHHHHHC | 1.56 | - | |
553 | Acetylation | VLMERLCKYIYAKDR HHHHHHHHHHHHCCC | 39.00 | 26051181 | |
553 | Ubiquitination | VLMERLCKYIYAKDR HHHHHHHHHHHHCCC | 39.00 | - | |
554 | Ubiquitination | LMERLCKYIYAKDRT HHHHHHHHHHHCCCC | 9.73 | - | |
558 | Acetylation | LCKYIYAKDRTDRIR HHHHHHHCCCCHHHH | 30.67 | 19608861 | |
559 | Acetylation | CKYIYAKDRTDRIRT HHHHHHCCCCHHHHH | 51.01 | 19608861 | |
559 | Ubiquitination | CKYIYAKDRTDRIRT HHHHHHCCCCHHHHH | 51.01 | 19608861 | |
612 | Phosphorylation | VQILYNRTMVQLGIC HHHEECCHHHHHHHH | 20.32 | - | |
627 | Acetylation | AFRQGLTKDAHNALL HHHCCCCCHHHHHHH | 58.94 | 26051181 | |
627 | Ubiquitination | AFRQGLTKDAHNALL HHHCCCCCHHHHHHH | 58.94 | 21906983 | |
628 | Ubiquitination | FRQGLTKDAHNALLD HHCCCCCHHHHHHHH | 48.07 | - | |
638 | Phosphorylation | NALLDIQSSGRAKEL HHHHHHHCCCHHHHH | 34.78 | 20873877 | |
639 | Phosphorylation | ALLDIQSSGRAKELL HHHHHHCCCHHHHHH | 18.87 | 20873877 | |
643 | Ubiquitination | IQSSGRAKELLGQGL HHCCCHHHHHHHHHH | 47.75 | 21890473 | |
643 | Acetylation | IQSSGRAKELLGQGL HHCCCHHHHHHHHHH | 47.75 | 26051181 | |
643 | Malonylation | IQSSGRAKELLGQGL HHCCCHHHHHHHHHH | 47.75 | 26320211 | |
643 | Ubiquitination | IQSSGRAKELLGQGL HHCCCHHHHHHHHHH | 47.75 | 21890473 | |
644 | Ubiquitination | QSSGRAKELLGQGLL HCCCHHHHHHHHHHH | 48.52 | - | |
653 | Methylation | LGQGLLLRSLQERNQ HHHHHHHHHHHHHHH | 34.98 | - | |
654 | Methylation | GQGLLLRSLQERNQE HHHHHHHHHHHHHHH | 34.08 | - | |
664 | Acetylation | ERNQEQEKVERRRQV HHHHHHHHHHHHHHC | 49.44 | 23749302 | |
664 | Ubiquitination | ERNQEQEKVERRRQV HHHHHHHHHHHHHHC | 49.44 | 21906983 | |
665 | Acetylation | RNQEQEKVERRRQVP HHHHHHHHHHHHHCC | 7.33 | - | |
665 | Ubiquitination | RNQEQEKVERRRQVP HHHHHHHHHHHHHCC | 7.33 | - | |
712 | Ubiquitination | ARRRMISKQFHHQLR HHHHHHHHHHHHHCC | 46.16 | 21890473 | |
712 | Acetylation | ARRRMISKQFHHQLR HHHHHHHHHHHHHCC | 46.16 | 23749302 | |
712 | Ubiquitination | ARRRMISKQFHHQLR HHHHHHHHHHHHHCC | 46.16 | 21906983 | |
713 | Acetylation | RRRMISKQFHHQLRV HHHHHHHHHHHHCCC | 35.79 | - | |
713 | Ubiquitination | RRRMISKQFHHQLRV HHHHHHHHHHHHCCC | 35.79 | - | |
719 | Methylation | KQFHHQLRVGERQPL HHHHHHCCCCCCCCC | 28.02 | - | |
720 | Methylation | QFHHQLRVGERQPLL HHHHHCCCCCCCCCC | 14.71 | - | |
732 | Phosphorylation | PLLGPPESMREHVVA CCCCCCHHHHHHHHH | 28.99 | 22985185 | |
733 | Phosphorylation | LLGPPESMREHVVAA CCCCCHHHHHHHHHH | 5.78 | - | |
742 | Ubiquitination | EHVVAASKAMKMGDW HHHHHHHHHHHCCCC | 48.01 | - | |
743 | Ubiquitination | HVVAASKAMKMGDWK HHHHHHHHHHCCCCC | 10.59 | - | |
745 | Acetylation | VAASKAMKMGDWKTC HHHHHHHHCCCCCCC | 44.59 | 25953088 | |
746 | Ubiquitination | AASKAMKMGDWKTCH HHHHHHHCCCCCCCE | 3.65 | - | |
750 | Acetylation | AMKMGDWKTCHSFII HHHCCCCCCCEEEEE | 46.12 | 26051181 | |
751 | Phosphorylation | MKMGDWKTCHSFIIN HHCCCCCCCEEEEEE | 15.93 | 21406692 | |
751 | Ubiquitination | MKMGDWKTCHSFIIN HHCCCCCCCEEEEEE | 15.93 | - | |
752 | Glutathionylation | KMGDWKTCHSFIINE HCCCCCCCEEEEEEH | 1.94 | 22555962 | |
754 | Phosphorylation | GDWKTCHSFIINEKM CCCCCCEEEEEEHHH | 21.93 | 21406692 | |
755 | Phosphorylation | DWKTCHSFIINEKMN CCCCCEEEEEEHHHC | 2.64 | - | |
760 | Ubiquitination | HSFIINEKMNGKVWD EEEEEEHHHCCCHHH | 32.93 | - | |
761 | Ubiquitination | SFIINEKMNGKVWDL EEEEEHHHCCCHHHC | 6.97 | - | |
764 | Acetylation | INEKMNGKVWDLFPE EEHHHCCCHHHCCCC | 34.84 | 26051181 | |
764 | Ubiquitination | INEKMNGKVWDLFPE EEHHHCCCHHHCCCC | 34.84 | - | |
765 | Ubiquitination | NEKMNGKVWDLFPEA EHHHCCCHHHCCCCH | 5.22 | - | |
774 | Acetylation | DLFPEADKVRTMLVR HCCCCHHHHHHHHHH | 40.44 | 26051181 | |
775 | Ubiquitination | LFPEADKVRTMLVRK CCCCHHHHHHHHHHH | 6.75 | - | |
787 | Phosphorylation | VRKIQEESLRTYLFT HHHHCHHHHHHHHHC | 23.54 | 21406692 | |
788 | Phosphorylation | RKIQEESLRTYLFTY HHHCHHHHHHHHHCC | 5.54 | - | |
820 | Phosphorylation | LDLPTVHSIISKMII CCHHHHHHHHHHHHC | 19.79 | 24719451 | |
839 | Phosphorylation | MASLDQPTQTVVMHR HHCCCCCCCEEEEEC | 31.10 | 20860994 | |
841 | Phosphorylation | SLDQPTQTVVMHRTE CCCCCCCEEEEECCC | 19.97 | 21601212 | |
847 | Phosphorylation | QTVVMHRTEPTAQQN CEEEEECCCCHHHHH | 31.47 | 20860994 | |
862 | Ubiquitination | LALQLAEKLGSLVEN HHHHHHHHHHHHHHC | 53.17 | 21890473 | |
862 | Ubiquitination | LALQLAEKLGSLVEN HHHHHHHHHHHHHHC | 53.17 | 21906983 | |
863 | Ubiquitination | ALQLAEKLGSLVENN HHHHHHHHHHHHHCC | 4.19 | - | |
865 | Phosphorylation | QLAEKLGSLVENNER HHHHHHHHHHHCCCC | 39.41 | 21815630 | |
866 | Phosphorylation | LAEKLGSLVENNERV HHHHHHHHHHCCCCE | 5.48 | - | |
877 | Ubiquitination | NERVFDHKQGTYGGY CCCEECCCCCCCCCC | 52.87 | 21890473 | |
877 | Acetylation | NERVFDHKQGTYGGY CCCEECCCCCCCCCC | 52.87 | 27452117 | |
877 | Ubiquitination | NERVFDHKQGTYGGY CCCEECCCCCCCCCC | 52.87 | 21906983 | |
878 | Ubiquitination | ERVFDHKQGTYGGYF CCEECCCCCCCCCCC | 46.14 | - | |
880 | Phosphorylation | VFDHKQGTYGGYFRD EECCCCCCCCCCCCC | 19.25 | 28152594 | |
881 | Phosphorylation | FDHKQGTYGGYFRDQ ECCCCCCCCCCCCCC | 18.51 | 28152594 | |
882 | Phosphorylation | DHKQGTYGGYFRDQK CCCCCCCCCCCCCCC | 24.94 | - | |
884 | Phosphorylation | KQGTYGGYFRDQKDG CCCCCCCCCCCCCCC | 7.35 | 28152594 | |
885 | Phosphorylation | QGTYGGYFRDQKDGY CCCCCCCCCCCCCCC | 8.63 | - | |
889 | Ubiquitination | GGYFRDQKDGYRKNE CCCCCCCCCCCCCCC | 58.36 | 21890473 | |
889 | Ubiquitination | GGYFRDQKDGYRKNE CCCCCCCCCCCCCCC | 58.36 | 21906983 | |
890 | Ubiquitination | GYFRDQKDGYRKNEG CCCCCCCCCCCCCCC | 54.44 | - | |
892 | Phosphorylation | FRDQKDGYRKNEGYM CCCCCCCCCCCCCCC | 28.66 | 29759185 | |
894 | Ubiquitination | DQKDGYRKNEGYMRR CCCCCCCCCCCCCCC | 51.36 | 21906983 | |
895 | Ubiquitination | QKDGYRKNEGYMRRG CCCCCCCCCCCCCCC | 38.64 | - | |
898 | Phosphorylation | GYRKNEGYMRRGGYR CCCCCCCCCCCCCCC | 4.93 | - | |
901 | Methylation | KNEGYMRRGGYRQQQ CCCCCCCCCCCCCCC | 26.76 | - | |
902 | Methylation | NEGYMRRGGYRQQQS CCCCCCCCCCCCCCC | 27.41 | - | |
904 | Phosphorylation | GYMRRGGYRQQQSQT CCCCCCCCCCCCCCC | 14.20 | 26074081 | |
909 | Phosphorylation | GGYRQQQSQTAY--- CCCCCCCCCCCC--- | 25.76 | 25159151 | |
910 | Phosphorylation | GYRQQQSQTAY---- CCCCCCCCCCC---- | 26.30 | 16964243 | |
911 | Phosphorylation | YRQQQSQTAY----- CCCCCCCCCC----- | 32.92 | 22617229 | |
913 | Phosphorylation | QQQSQTAY------- CCCCCCCC------- | 23.60 | 22199227 | |
914 | Phosphorylation | QQSQTAY-------- CCCCCCC-------- | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EIF3C_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EIF3C_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EIF3C_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-558, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9 AND SER-39, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39 AND SER-166, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6; SER-9; SER-11;SER-13; SER-15; SER-16; SER-18; SER-39; SER-166; SER-178; SER-181 ANDSER-182, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39 AND SER-166, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39 AND SER-166, AND MASSSPECTROMETRY. | |
"Structural characterization of the human eukaryotic initiation factor3 protein complex by mass spectrometry."; Damoc E., Fraser C.S., Zhou M., Videler H., Mayeur G.L.,Hershey J.W.B., Doudna J.A., Robinson C.V., Leary J.A.; Mol. Cell. Proteomics 6:1135-1146(2007). Cited for: IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3COMPLEX, PHOSPHORYLATION AT SER-9; SER-11; SER-13; SER-15; SER-16;SER-18; SER-39; SER-166; THR-524 AND SER-909, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-166 AND SER-909,AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-95; SER-166;SER-178; SER-181 AND SER-182, AND MASS SPECTROMETRY. | |
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39, AND MASSSPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-909, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-166 AND THR-524, ANDMASS SPECTROMETRY. |